Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis.
about
A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancerSurgery for Colorectal Cancer - Trends, Developments, and Future PerspectivesResection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomesPreoperative selection of patients with colorectal cancer liver metastasis for hepatic resectionRole of surgery in colorectal cancer liver metastasesDesigning liver resections and pushing the envelope with resections for hepatic colorectal metastasesSurrogate endpoints in liver surgery related trials: a systematic review of the literatureSurgery for colorectal liver metastases: The evolution of determining prognosisSelection for hepatic resection of colorectal liver metastases: expert consensus statementOutcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases.Colorectal cancer: from prevention to personalized medicine.Debulking treatment with CT-guided percutaneous radiofrequency ablation and hepatic artery infusion of floxuridine improves survival of patients with unresectable pulmonary and hepatic metastases of colorectal cancerThoracic surgical management of colorectal lung metastases: a questionnaire survey of members of the Society for Cardiothoracic Surgery in Great Britain and Ireland.SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancerSynchronous Resectable Metastatic Colorectal Cancer: Lymph Node Involvement Predicts Poor Outcome.Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making.What is the optimal neo-adjuvant treatment for liver metastasis?Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 3: CONTROVERSIES AND UNRESECTABLE METASTASES.Debulking surgery in advanced melanoma.Prognostic factors after resection of colorectal liver metastases: from morphology to biology.Advances in understanding of colorectal liver metastasis and implications for the clinic.Liver-directed therapies in metastatic colorectal cancer.Contemporary surgical options for metastatic colorectal cancer.Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.Management of patients with colorectal liver metastasis in eleven questions and answers.Population-based study on resection rates and survival in patients with colorectal liver metastasis in Norway.Safety and efficacy of microwave ablation for medically inoperable colorectal pulmonary metastases: Single-centre experience.Survival Following Resection of Intra- and Extra-Hepatic Metastases from Colorectal Cancer: A Phase II Trial.The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.Resection of non-hepatic colorectal cancer metastasisOutcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.[Assessment of resectability of colorectal liver metastases and extended resection].Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection.Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.The impact of extrahepatic disease among patients undergoing liver-directed therapy for neuroendocrine liver metastasis.Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study.The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors.
P2860
Q24629242-1E7FFDD4-8C80-488C-B26F-7494D1576EE3Q26738796-CB617886-5386-485D-B456-81BB17D5B0CBQ26750691-DA9C7A66-5B0D-4985-85C1-BDB0A518E7EBQ26774687-61873B66-B097-4087-9E0A-13369855F4F9Q26830444-AD4CF6E4-EC14-4497-BB6A-C985EA9EE23CQ26864128-7B7A2AF0-94DE-4610-8C76-8E435A5C01ACQ27022533-6CCFBF67-26E8-4E62-8F53-E8608377B8D4Q27694490-916815E5-554E-49CE-B86D-F9BB8915C136Q30415026-7C3B5713-9F7E-43B2-9430-DE7F19C37023Q33720942-734F3F77-A7C8-4C05-818A-1AA844012C77Q33735234-9AD6317F-66B2-4D80-817E-6AD856605899Q33764110-741FA96F-C7CF-42A5-9AB8-6E6689810949Q33902326-D705BE25-4FD7-456E-A1F0-5F6A9203E041Q35021702-1B06A452-920B-43CB-8282-5EDF9083EA39Q36009386-C47F1DE0-2914-4490-9B38-E282D382DC5FQ36524431-D9233810-E9E8-4393-98F0-260D1F47E3F2Q36537666-D4EA1432-7178-406C-9368-2B982479B0B3Q36999699-25D229B4-FFEC-4064-AAE3-EA34F528409FQ37308725-5FE85090-7F72-42BB-B7E2-28DF6C1B7717Q37358002-4D6FADE2-4E62-4F76-9B1B-197C9ECBC4C1Q37952238-1BEF0EC4-35CD-4ED4-A1F1-A6E7B07E77E4Q38068492-C6166B60-6134-4B58-8346-5D20BF1B49E0Q38230654-7CCF3EFA-31F8-464E-8281-F9D4B2847B8EQ38256165-2A1E2962-D3BD-483E-9891-824E3B5E03A6Q38364613-C6B49EAD-589F-43C3-B306-2D0E0C3C5F76Q38696070-ED7855D4-549D-4AD5-B934-5B7754127974Q38811107-1D084136-957A-49C1-B8FF-4C1AA59390F9Q38970211-3CC9DECB-AB5D-4875-8D97-326909AFEBDBQ39165247-AC12CDC6-61D9-4ACD-A078-CEBF08657FA5Q39878611-1AB8E27F-0EBB-48E5-835A-96C39689CC2DQ40509254-EA88F3B7-5120-4512-91A4-E6600D933A5DQ41852206-877881E5-073E-44F4-B30A-D00874531BB8Q43413801-B84A76FF-767E-4752-95F4-885FC6EAD470Q43479654-E139F7B4-4228-4C62-BD15-C2364F3E4F81Q43798315-007203A6-6E54-4B5A-9CE8-58B764534E97Q44399724-04AA51C2-5CF0-4774-B29C-2AF3A9543A1AQ45062084-24B918FF-BA61-46EA-91EC-77926F9A4462Q46463662-7DA88D96-C2B7-415B-8D07-4ABBDE093DD1Q48230454-47FCBDC5-176C-46DE-A029-22E89359C895Q55301332-7040363C-094C-471A-885C-D245D6BD3498
P2860
Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Liver resection for colorectal ...... multi-institutional analysis.
@ast
Liver resection for colorectal ...... multi-institutional analysis.
@en
Liver resection for colorectal ...... multi-institutional analysis.
@nl
type
label
Liver resection for colorectal ...... multi-institutional analysis.
@ast
Liver resection for colorectal ...... multi-institutional analysis.
@en
Liver resection for colorectal ...... multi-institutional analysis.
@nl
prefLabel
Liver resection for colorectal ...... multi-institutional analysis.
@ast
Liver resection for colorectal ...... multi-institutional analysis.
@en
Liver resection for colorectal ...... multi-institutional analysis.
@nl
P2093
P2860
P50
P1476
Liver resection for colorectal ...... l multi-institutional analysis
@en
P2093
Carlo Pulitanò
Federico Castillo
Luca Aldrighetti
Martin Bodingbauer
Mechteld C de Jong
Michael A Choti
Richard D Schulick
Rowan W Parks
P2860
P2888
P304
P356
10.1245/S10434-010-1459-4
P577
2010-12-07T00:00:00Z
P6179
1038039517